Indefinite Delivery Contract SPE2D226D0002
- Not listed
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain on September 22, 2020, with a ceiling value of $5.12 million and an ultimate completion date of September 21, 2025. This unrestricted contract, issued without small business set-aside designations, establishes Avkare as a prime contractor for the manufacture and distribution of pharmaceutical...
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency Medical Supply Chain on December 8, 2021, with a ceiling value of $16.7 million and an ultimate completion date of December 7, 2026. The contract was awarded on an unrestricted, competitive basis without small business set-aside designations. As a manufacturer and distributor of pharmaceutical products and medical...
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain on March 7, 2023, with a ceiling value of approximately $4.9 million and an ultimate completion date of March 7, 2033. The contract encompasses the pharmaceutical manufacturing and distribution division under the Federal Supply Agreement, with no small business set-aside designation, allowing Avkare...
- This single-award Indefinite Delivery Contract was granted to Avkare LLC, a pharmaceutical and medical supply distributor headquartered in Pulaski, Tennessee, on September 16, 2020, with an ultimate completion date of September 15, 2025. The contract, funded by the Defense Logistics Agency's Medical Supply Chain (a defense-focused federal agency), carries a ceiling value of $5,934,599.30 and was awarded without set-aside restrictions, enabling the contractor to compete on an unrestricted...
- Avkare LLC has been awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency (DLA) Medical Supply Chain with a ceiling value of $39.51 million and a period of performance extending from October 16, 2025, through October 15, 2030. This unrestricted, fully competitive procurement was established to support the DLA's national requirements for Potassium Chloride Extended Release Tablets, available in 10 milliequivalent and 20 milliequivalent formulations in various...
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a multiple-award Federal Supply Schedule contract under General Services Administration Schedule 61-IB (Pharmaceuticals and Drugs) on June 15, 2023, with a ceiling value of $1.637 billion and an ultimate completion date of June 14, 2028. This civilian contract is funded through the Veterans Integrated Service Network 12, a component of the Department of Veterans Affairs. The contract includes a...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $62,144,789.65 contract has a period of performance through April 2025 and allows the DLA, Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons (BOP) to issue task orders for a variety of pharmaceutical and medical products. The original solicitation sought offers for a...
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs National Acquisition Center on July 15, 2024, with a ceiling value of $1,244,773.20. The contract encompasses a one-year base period plus four one-year option periods, with an ultimate completion date of July 14, 2026. The primary product being procured is tenofovir disoproxil fumarate 300 mg tablets, with...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract to Avkare, LLC, a for-profit limited liability company. The contract, with a potential value of $31,732,179.00, aims to provide a national supply source for the procurement of pharmaceutical products, medical equipment, and other healthcare supplies by federal agencies including the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs....
- Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain on October 5, 2022, with a ceiling value of $43.14 million and an ultimate completion date of October 4, 2027. This unrestricted contract, not utilizing any small business set-aside, establishes Avkare as the national requirements supplier for Estradiol Tablets in 8 and 18 count packs to support...
Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, has been awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency's Medical Supply Chain with a ceiling value of $64.6 million. The contract, effective from December 11, 2025, through December 10, 2030, establishes Avkare as a national supply source for Telmisartan tablets in 20 milligram, 40 milligram, and 80 milligram strengths under a firm-fixed price, requirements-type contract structure with a one-year base period and four one-year renewal options. This unrestricted, fully competitive commercial item acquisition under Federal Acquisition Regulation Part 12 will serve federal healthcare beneficiaries across the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs through the Defense Logistics Agency and Veterans Affairs prime vendor programs. As a proven supplier within the federal pharmaceutical procurement landscape, Avkare brings substantial relevant experience delivering generic medications and specialized pharmaceutical products to multiple federal healthcare agencies. The company currently maintains a $1.637 billion General Services Administration Schedule contract for pharmaceuticals and a portfolio of single-award Indefinite Delivery Contracts with the Department of Veterans Affairs National Acquisition Center and Defense Logistics Agency Troop Support Medical, including contracts for high-value pharmaceutical products such as Metformin Hydrochloride sustained-release tablets and other specialty medications. This Telmisartan contract leverages Avkare's established distribution capabilities and supply chain infrastructure to meet the antihypertensive medication requirements of federal healthcare organizations through delivery orders issued against the blanket purchasing agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 12/10/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Telmisartan Tablets | SPE2D2-24-R-0015 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/3 | 7/23/24, 10:50 AM | |
Telmisartan Tablets | SPE2E2-24-R-0015 | Defense Logistics Agency Troop Support Medical | Solicitation 2/3 | 1/8/25, 10:34 AM | |
Telmisartan Tablets | SPE2D2-26-D-0002 | Defense Logistics Agency Troop Support Medical | Award Notice 3/3 | 12/11/25, 2:13 PM |